End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.98 CNY | +0.85% | -1.81% | -4.98% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.98% | 1.28B | - | ||
+14.62% | 65.37B | A- | ||
+0.47% | 48.63B | A- | ||
+20.87% | 42.74B | B+ | ||
+26.01% | 27.7B | A- | ||
+8.88% | 19.15B | C+ | ||
-4.28% | 16.52B | B+ | ||
+7.89% | 16.29B | B+ | ||
-28.97% | 15.21B | A- | ||
-14.16% | 15.02B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 603281 Stock
- Ratings Hubei Jianghan New Materials Co., Ltd.